Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
14.51
+0.01 (0.07%)
At close: Sep 18, 2026, 4:00 PM EDT
14.68
+0.17 (1.17%)
Pre-market: Sep 21, 2026, 9:00 AM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | +24.05% | Sep 21, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $18 → $20 | Hold | Reiterates | $18 → $20 | +37.84% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $33 | Buy | Maintains | $33 | +127.43% | Sep 18, 2026 |
| Wedbush | Wedbush | Hold Maintains $23 | Hold | Maintains | $23 | +58.51% | Sep 18, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $37 → $39 | Buy | Reiterates | $37 → $39 | +168.78% | Sep 18, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $33 → $39 | Buy | Maintains | $33 → $39 | +168.78% | Sep 18, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $18 | Hold | Reiterates | $18 | +24.05% | Sep 18, 2026 |
| Citi | Citi | Buy Maintains $31 → $32 | Buy | Maintains | $31 → $32 | +120.54% | Sep 18, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.